Health Canada approves submission that could make Pfizer-BioNTech’s COVID-19 vaccine more easily transported

 

If you're frustrated with the slow pace Canadians have been vaccinated for COVID-19 thus far, there's good news.

Health Canada has announced it has approved a submission from Pfizer-BioNTech, which would allow for easier transportation of the vaccine.

Now, rather than the ultra cold temperature in which the vaccine previously had to be transported, it can be transported at regular freezer temperatures--between -25degC and -15degC.

Additionally, the vials can be stored and transported at this temperature for up to two weeks--it can also be stored once at the previous temperatures--between -80degC to -60degC.

According to Health Canada, a thorough review of Pfizer-BioNTech's submission indicated the vaccine remains stable and effective when stored at regular, freezer temperatures for up to two weeks, meaning it meets Health Canada’s quality standards.

However, despite this, ultra-cold conditions are still recommended for storing and transporting the vaccine.